IKONISYS EO 2
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more
IKONISYS EO 2 (9W8) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, IKONISYS EO 2 (9W8) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
IKONISYS EO 2 - Net Assets Trend (None–None)
This chart illustrates how IKONISYS EO 2's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for IKONISYS EO 2 (None–None)
The table below shows the annual net assets of IKONISYS EO 2 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to IKONISYS EO 2's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
IKONISYS EO 2 Competitors by Market Cap
The table below lists competitors of IKONISYS EO 2 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Luda Technology Group Limited
NYSE MKT:LUD
|
$10.25 Million |
|
Wesizwe Platinum Limited
PINK:WSZWF
|
$10.25 Million |
|
Harn Engineering Solutions Public Company Limited
BK:HARN
|
$10.25 Million |
|
Spruce Ridge Resources Ltd
OTCQB:SRCGF
|
$10.26 Million |
|
Swoop Holdings Ltd
AU:SWP
|
$10.24 Million |
|
Stel Holdings Limited
NSE:STEL
|
$10.23 Million |
|
Viking Mines Limited
F:AVI
|
$10.23 Million |
|
RIV Capital Inc
PINK:CNPOF
|
$10.23 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IKONISYS EO 2's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares IKONISYS EO 2's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently IKONISYS EO 2 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares IKONISYS EO 2's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IKONISYS EO 2 (9W8) | €- | N/A | N/A | $10.25 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |